Dr. Copelan discusses the use of chimeric antigen receptor (CAR) T-cell therapy in non-Hodgkin lymphoma patients and how these therapies might improve upon the current standard of care.
Edward A. Copelan, MD
Advertisement
Articles by Edward A. Copelan, MD
Advertisement
Latest Updated Articles
CAR T-Cell Therapy in Non-Hodgkin Lymphoma PatientsPublished: February 15th 2019 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
How Will the Continued Success of ADCs in Breast Cancer Be Propelled in the Future?
2
Trial Assessing Savolitinib/Osimertinib in NSCLC Completes Enrollment
3
Searching for Synergy in Liver-Dominant Neuroendocrine Tumors
4
Neoadjuvant Nivolumab/Ipilimumab Shows Superior EFS in Resectable Melanoma
5
